Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rafael Guimarães dos Santos. (2014) Immunological Effects of Ayahuasca in Humans. Journal of Psychoactive Drugs 46:5, pages 383-388.
Read now
Read now
Articles from other publishers (22)
Paweł Holas & Justyna Kamińska. (2023) Mindfulness meditation and psychedelics: potential synergies and commonalities. Pharmacological Reports 75:6, pages 1398-1409.
Crossref
Crossref
Blerida Banushi & Vince Polito. (2023) A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics. Biology 12:11, pages 1380.
Crossref
Crossref
Akash Goel, Yeshith Rai, Shayan Sivadas, Calvin Diep, Hance Clarke, Harsha Shanthanna & Karim S. Ladha. (2023) Use of Psychedelics for Pain: A Scoping Review. Anesthesiology 139:4, pages 523-536.
Crossref
Crossref
Barbara G. Ferri, Cintia O. de Novais, Raquel S. Bonani, Wellington A. de Barros, Ângelo de Fátima, Fabiana C. Vilela & Alexandre Giusti-Paiva. (2023) Psychoactive substances 25H-NBOMe and 25H-NBOH induce antidepressant-like behavior in male rats. European Journal of Pharmacology 955, pages 175926.
Crossref
Crossref
Rabeet Tariq. (2023) Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and
Potential Harms. Current Reviews in Clinical and Experimental Pharmacology 18:2, pages 94-109.
Crossref
Crossref
Noah D. Gold, Samantha K. PodrebaracLindsay A. WhiteChristina MariniNaomi M. SimonMary S. MittelmanStephen RossMichael P. BogenschutzPetros D. Petridis. (2023) Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress. Psychedelic Medicine 1:2, pages 87-97.
Crossref
Crossref
Antonio Inserra, Giada Giorgini, Sebastien Lacroix, Antonella Bertazzo, Jocelyn Choo, Athanasios Markopolous, Emily Grant, Armita Abolghasemi, Danilo De Gregorio, Nicolas Flamand, Geraint Rogers, Stefano Comai, Cristoforo Silvestri, Gabriella Gobbi & Vincenzo Di Marzo. (2022) Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome. British Journal of Pharmacology 180:6, pages 721-739.
Crossref
Crossref
Lucas Dwiel, Angela HenricksElise BraggJeff NicolJiang GuiWilder Doucette. (2023) Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents. Psychedelic Medicine 1:1, pages 43-53.
Crossref
Crossref
Muhammad Ishrat Husain, Nicole Ledwos, Elise Fellows, Jenna Baer, Joshua D. Rosenblat, Daniel M. Blumberger, Benoit H. Mulsant & David J. Castle. (2023) Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?. Frontiers in Psychiatry 13.
Crossref
Crossref
Geoffrey M. Bove & David J. Mokler. (2022) Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum. Journal of Psychedelic Studies.
Crossref
Crossref
Sierra Simpson, Rio Mclellan, Emma Wellmeyer, Frederic Matalon & Olivier George. (2021) Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders. Journal of Neuroimmune Pharmacology 17:1-2, pages 33-61.
Crossref
Crossref
Susan Ling, Felicia Ceban, Leanna M. W. Lui, Yena Lee, Kayla M. Teopiz, Nelson B. Rodrigues, Orly Lipsitz, Hartej Gill, Mehala Subramaniapillai, Rodrigo B. Mansur, Kangguang Lin, Roger Ho, Joshua D. Rosenblat, David Castle & Roger S. McIntyre. (2021) Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. CNS Drugs 36:1, pages 17-30.
Crossref
Crossref
Shariq Mansoor Khan, Gregory T. Carter, Sunil K. Aggarwal & Julie Holland. (2021) Psychedelics for Brain Injury: A Mini-Review. Frontiers in Neurology 12.
Crossref
Crossref
Antonio Inserra, Danilo De Gregorio & Gabriella Gobbi. (2020) Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews 73:1, pages 202-277.
Crossref
Crossref
Caitlin Thompson & Attila Szabo. (2020) Psychedelics as a novel approach to treating autoimmune conditions. Immunology Letters 228, pages 45-54.
Crossref
Crossref
Kristin Heuschkel & Kim P.C. Kuypers. (2020) Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review. Frontiers in Psychiatry 11.
Crossref
Crossref
Silvia Muttoni, Maddalena Ardissino & Christopher John. (2019) Classical psychedelics for the treatment of depression and anxiety: A systematic review. Journal of Affective Disorders 258, pages 11-24.
Crossref
Crossref
Vanja Dakic, Juliana Minardi Nascimento, Rafaela Costa Sartore, Renata de Moraes Maciel, Draulio B. de Araujo, Sidarta Ribeiro, Daniel Martins-de-Souza & Stevens K. Rehen. (2017) Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Scientific Reports 7:1.
Crossref
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi & Jaime E. C. Hallak. (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 6:3, pages 193-213.
Crossref
Crossref
Melissa M. Gomes, Felipe A. Dörr, Luiz H. Catalani & Ana Campa. (2012) Oxidation of lysergic acid diethylamide (LSD) by peroxidases: a new metabolic pathway. Forensic Toxicology 30:2, pages 87-97.
Crossref
Crossref
Hyoung-Chun Kim, Wang-Kee Jhoo, Myung-Sang Kwan & Jau-Shyong Hong. (1995) Effects of chronic dextromethorphan administration on the cellular immune responses in mice. Archives of Pharmacal Research 18:4, pages 267-270.
Crossref
Crossref
Peter T. Thomas, Robert V. House & Hemendra N. Bhargava. (1995) Direct cellular immunomodulation produced by Diacetylmorphine (heroin) or methadone. General Pharmacology: The Vascular System 26:1, pages 123-130.
Crossref
Crossref